Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
verahealth.ai > zh > news > grpr-positive-solid-tumors-177lu-neob-shows-early-activity-with-a-manageable-saf

GRPR-positive solid tumors: 177Lu-NeoB shows early activity with a manageable safety profile - Vera Health News

1+ week, 11+ hour ago   (14+ words) GRPR-positive solid tumors: 177Lu-NeoB shows early activity with a manageable safety profile Vera Health...

Google News
verahealth.ai > fr > news > resectable-pancreatic-cancer-biweekly-gemcitabine-cisplatin-nab-paclitaxel-shows

Resectable pancreatic cancer: Biweekly gemcitabine cisplatin nab-paclitaxel shows high R0 resection rates - Actualités Vera Health

2+ week, 18+ hour ago   (14+ words) Resectable pancreatic cancer: Biweekly gemcitabine cisplatin nab-paclitaxel shows high R0 resection rates Vera Health...

Google News
verahealth.ai > de > news > borrmann-type-iv-gastric-cancer-total-neoadjuvant-pd-1-plus-chemotherapy-deliver

Borrmann type IV gastric cancer: Total neoadjuvant PD-1 plus chemotherapy delivers meaningful pathologic response - Vera Health News

2+ week, 15+ hour ago   (16+ words) Borrmann type IV gastric cancer: Total neoadjuvant PD-1 plus chemotherapy delivers meaningful pathologic response Vera Health...